EUVIMEDEUVIMED entdecken
Open Access

Molecular Assay and Genotyping of Hepatitis C Virus among Infected Egyptian and Saudi Arabian Patients

Mohamed Ms Farag, Ahmed R Sofy, Adel A Mousa, Mohamed A Ahmed, Mohamed R Alganzory

Virology: Research and Treatment · 2015

DOI: 10.4137/vrt.s32016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Virology: Research and Treatment, 2015. Verfasst von Mohamed Ms Farag und 4 weiteren Autor:innen. Beteiligte Einrichtung: Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Nasr City, Cairo, Egypt. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis C virus (HCV) infection is a major health problem recognized globally. HCV is a common cause of liver fibrosis that may lead to liver cirrhosis or hepatocellular carcinoma. The aim of this study was to estimate the prevalence of HCV infection and genotyping among Egyptian and Saudi Arabian chronic patients using different molecular techniques. HCV RNA viral load was assessed by real-time polymerase chain reaction (RT-PCR) technology. For HCV genotyping, RT-PCR hybridization fluorescence-based method and reverse hybridization line probe assay (INNO-LiPA) were used. A total of 40 anti-HCV-positive patients with chronic hepatitis C were examined for HCV RNA, genotyping, and different laboratory investigations. In the present study, HCV genotypes 4, mixed 4.1b, and 1 were detected in patients of both countries, while genotype 2 was only detected in Saudi Arabian patients. Genotyping methods for HCV showed no difference in the classification at the genotype level. With regard to HCV subtypes, INNO-LiPA assay was a reliable test in HCV genotyping for the detection of major genotypes and subtypes, while RT-PCR-based assay was a good test at the genotype level only. HCV genotype 4 was found to be the predominant genotype among Egyptian and Saudi Arabian chronic patients. In conclusion, data analysis for detecting and genotyping HCV was an important factor for understanding the epidemiology and treatment strategies of HCV among Egyptian and Saudi Arabian chronic patients.

Schlagwörter

Stichwörter der Autor:innen

HCV RNAdetectiongenotypingprevalence

Autor:innen und Institutionen

  • Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Nasr City, Cairo, Egypt.
  • Clinical Pathology Department, Military Medical Academy, Cairo, Egypt.
  • Basic Science Department, College of Dentistry, Majma'ah University, Al Majma'ah, Kingdom of Saudi Arabia.

Zitieren

APA

Farag, M. M., Sofy, A. R., Mousa, A. A., Ahmed, M. A., & Alganzory, M. R. (2015). Molecular Assay and Genotyping of Hepatitis C Virus among Infected Egyptian and Saudi Arabian Patients. Virology: Research and Treatment. https://doi.org/10.4137/vrt.s32016

Vancouver

Farag MM, Sofy AR, Mousa AA, Ahmed MA, Alganzory MR. Molecular Assay and Genotyping of Hepatitis C Virus among Infected Egyptian and Saudi Arabian Patients. Virology: Research and Treatment. 2015. doi:10.4137/vrt.s32016

BibTeX
@article{Farag2015,
  author = {Farag, Mohamed Ms and Sofy, Ahmed R and Mousa, Adel A and Ahmed, Mohamed A and Alganzory, Mohamed R},
  title = {Molecular Assay and Genotyping of Hepatitis C Virus among Infected Egyptian and Saudi Arabian Patients},
  journal = {Virology: Research and Treatment},
  year = {2015},
  doi = {10.4137/vrt.s32016}
}
Kostenlos starten →